Hanauer SB - Search Results

1

Time to Symptom Resolution in Ulcerative Colitis With Multimatrix Mesalazine Treatment: A Pooled Analysis.

Schreiber S, Hanauer SB, Sandborn WJ, Barrett K. Schreiber S, et al. Among authors: hanauer sb. J Crohns Colitis. 2020 Sep 16;14(9):1274-1281. doi: 10.1093/ecco-jcc/jjaa041. J Crohns Colitis. 2020. PMID: 32179906 Review.

2

The management of ulcerative colitis.

Hanauer SB, Baert FJ. Hanauer SB, et al. Annu Rev Med. 1995;46:497-505. doi: 10.1146/annurev.med.46.1.497. Annu Rev Med. 1995. PMID: 7598482 Review.

3

Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group.

Hanauer S, Schwartz J, Robinson M, Roufail W, Arora S, Cello J, Safdi M. Hanauer S, et al. Am J Gastroenterol. 1993 Aug;88(8):1188-97. Am J Gastroenterol. 1993. PMID: 8338086 Clinical Trial.

4

Dose-ranging study of mesalamine (PENTASA) enemas in the treatment of acute ulcerative proctosigmoiditis: results of a multicentered placebo-controlled trial. The U.S. PENTASA Enema Study Group.

Hanauer SB. Hanauer SB. Inflamm Bowel Dis. 1998 May;4(2):79-83. doi: 10.1002/ibd.3780040202. Inflamm Bowel Dis. 1998. PMID: 9589293 Clinical Trial.

5

Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study group.

Hanauer SB, Robinson M, Pruitt R, Lazenby AJ, Persson T, Nilsson LG, Walton-Bowen K, Haskell LP, Levine JG. Hanauer SB, et al. Gastroenterology. 1998 Sep;115(3):525-32. doi: 10.1016/s0016-5085(98)70131-3. Gastroenterology. 1998. PMID: 9721148 Clinical Trial.

6

Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety.

Sandborn WJ, Hanauer SB. Sandborn WJ, et al. Among authors: hanauer sb. Inflamm Bowel Dis. 1999 May;5(2):119-33. doi: 10.1097/00054725-199905000-00008. Inflamm Bowel Dis. 1999. PMID: 10338381 Review.

7

Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group.

Sandborn WJ, Tremaine WJ, Wolf DC, Targan SR, Sninsky CA, Sutherland LR, Hanauer SB, McDonald JW, Feagan BG, Fedorak RN, Isaacs KL, Pike MG, Mays DC, Lipsky JJ, Gordon S, Kleoudis CS, Murdock RH Jr. Sandborn WJ, et al. Among authors: hanauer sb. Gastroenterology. 1999 Sep;117(3):527-35. doi: 10.1016/s0016-5085(99)70445-2. Gastroenterology. 1999. PMID: 10464128 Clinical Trial.

8

A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.

Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, Jewell DP, Rachmilewitz D, Sachar DB, Sandborn WJ, Sutherland LR. Gasche C, et al. Among authors: hanauer sb. Inflamm Bowel Dis. 2000 Feb;6(1):8-15. doi: 10.1097/00054725-200002000-00002. Inflamm Bowel Dis. 2000. PMID: 10701144

9

A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis.

Cohen RD, Woseth DM, Thisted RA, Hanauer SB. Cohen RD, et al. Among authors: hanauer sb. Am J Gastroenterol. 2000 May;95(5):1263-76. doi: 10.1111/j.1572-0241.2000.01940.x. Am J Gastroenterol. 2000. PMID: 10811338

10

Long-term use of mesalamine (Rowasa) suppositories in remission maintenance of ulcerative proctitis.

Hanauer S, Good LI, Goodman MW, Pizinger RJ, Strum WB, Lyss C, Haber G, Williams CN, Robinson M. Hanauer S, et al. Am J Gastroenterol. 2000 Jul;95(7):1749-54. doi: 10.1111/j.1572-0241.2000.02185.x. Am J Gastroenterol. 2000. PMID: 10925979 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

553 results

Search Page

Filters